AstraZeneca strikes deal for up to $18.5 billion to license weight-loss drugs from China's CSPC
By Andrew Silver SHANGHAI, Jan 30 (Reuters) - AstraZeneca will license experimental drugs for obesit...
30th January, 2026
By Andrew Silver SHANGHAI, Jan 30 (Reuters) - AstraZeneca will license experimental drugs for obesit...
30th January, 2026
MILAN, Jan 30 (Reuters) - Stellantis expects to increase its output in Italy this year thanks to new...
30th January, 2026
Jan 30 (Reuters) - Car safety gear maker Autoliv forecast on Friday a full-year 2026 adjusted opera...
30th January, 2026
By Alessandro Parodi Jan 29 (Reuters) - In Italy's storied gold‑making hubs, jewellers are reworking...
30th January, 2026
Jan 30 (Reuters) - Australia's Electro Optic Systems (EOS) is "very likely" to shift its headquarter...
30th January, 2026
By Maria Martinez BERLIN, Jan 30 (Reuters) - Germany's Economy Minister Katherina Reiche said on Fri...
30th January, 2026
PARIS, Jan 30 (Reuters) - French Finance Minister Roland Lescure said on Friday he had decided earli...
30th January, 2026
Jan 30 (Reuters) - Apple is prioritizing production and shipment of its three highest-end iPhone mod...
30th January, 2026
Commercial lending has always been complex, involving multiple stakeholders and varying risk profile...
30th January, 2026
TAIPEI, Jan 30 (Reuters) - Taiwan completed the maiden underwater sea trial for its first domestical...
30th January, 2026
By Bageshri Banerjee Jan 22 - Medical equipment maker Stryker raised its full-year profit forecast o...
29th January, 2026
By Stephen Nellis Jan 29 (Reuters) - Apple beat Wall Street estimates for quarterly revenue on Thurs...
29th January, 2026